Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WDR54 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PSMG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JMJD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN5P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TRIM72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ANKRD23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WHSC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTHFD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105372547 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPCAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFRD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT83 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on